Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development

被引:0
|
作者
Qianya Wan
Dan Song
Huangcan Li
Ming-liang He
机构
[1] City University of Hong Kong,Department of Biomedical Sciences
[2] CityU Shenzhen Research Institute,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Stress proteins (SPs) including heat-shock proteins (HSPs), RNA chaperones, and ER associated stress proteins are molecular chaperones essential for cellular homeostasis. The major functions of HSPs include chaperoning misfolded or unfolded polypeptides, protecting cells from toxic stress, and presenting immune and inflammatory cytokines. Regarded as a double-edged sword, HSPs also cooperate with numerous viruses and cancer cells to promote their survival. RNA chaperones are a group of heterogeneous nuclear ribonucleoproteins (hnRNPs), which are essential factors for manipulating both the functions and metabolisms of pre-mRNAs/hnRNAs transcribed by RNA polymerase II. hnRNPs involve in a large number of cellular processes, including chromatin remodelling, transcription regulation, RNP assembly and stabilization, RNA export, virus replication, histone-like nucleoid structuring, and even intracellular immunity. Dysregulation of stress proteins is associated with many human diseases including human cancer, cardiovascular diseases, neurodegenerative diseases (e.g., Parkinson’s diseases, Alzheimer disease), stroke and infectious diseases. In this review, we summarized the biologic function of stress proteins, and current progress on their mechanisms related to virus reproduction and diseases caused by virus infections. As SPs also attract a great interest as potential antiviral targets (e.g., COVID-19), we also discuss the present progress and challenges in this area of HSP-based drug development, as well as with compounds already under clinical evaluation.
引用
收藏
相关论文
共 37 条
  • [21] Cellular IMAGING-BASED biological analysis for cancer diagnostics and drug target development
    Kim, D
    Yeom, YI
    2005 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOLS 1-5: SPEECH PROCESSING, 2005, : 841 - 844
  • [22] Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development
    Pielnaa, Paul
    Al-Saadawe, Moyed
    Saro, Adonira
    Dama, Marcelllin Faniriantsoahenrio
    Zhou, Mei
    Huang, Yanxia
    Huang, Jufang
    Xia, Zanxian
    VIROLOGY, 2020, 543 : 34 - 42
  • [23] Editorial: Antiviral drug discovery against pathogens of pandemic concern: Advancements in target site identification and structure-based drug development
    Das, Krishna Padmanabha M.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [24] TARGET BASED PHARMACOLOGICAL APPROACHES FOR DRUG DEVELOPMENT AGAINST NOVEL CORONA VIRUS (COVID-19)
    Hoda, Quaisul
    Fatma, Askary
    Pahwa, Shilpa
    Gupta, Chitra
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (11): : 5284 - 5289
  • [25] STRUCTURE OF THE HEPATITIS B VIRUS RNase H, A TARGET FOR NEW ANTIVIRAL DRUG DEVELOPMENT, UNRAVELED BY ULTRA-DEEP PYROSEQUENCING AND MOLECULAR MODELING
    Hayer, J.
    Rodriguez, C.
    Germanidis, G.
    Deleage, G.
    Zoulim, F.
    Pawlotsky, J. -M.
    Combet, C.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S55 - S55
  • [26] A simulation-based approach to target Zika virus RNA-dependent RNA polymerase with marine compounds for antiviral development
    Sharma, Pradeep
    Moustafa, Mahmoud
    Al-Shehri, Mohammed
    Alotaibi, Faisal
    Bhardwaj, Rima
    Singh, Indrakant K.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
  • [27] Biological activities of 4H-thiochromen-4-one 1,1-dioxide derivatives against tropical disease parasites: A target-based drug design approach
    Ortiz, Cristian
    Breuning, Matthias
    Robledo, Sara
    Echeverri, Fernando
    Vargas, Esteban
    Quinones, Wiston
    HELIYON, 2023, 9 (07)
  • [28] Target-based therapeutic matching of phase I trials in patients with advanced breast cancer (BC pts) in the Royal Marsden Hospital Drug Development Unit (RMH DDU).
    O'Carrigan, Brent
    Jalil, Awais
    Papadatos-Pastos, Dionysios
    Harris, Samuel John
    Lopez, Juanita Suzanne
    Banerji, Udai
    De Bono, Johann S.
    Yap, Timothy Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Characterization of a Proteolytically Stable D-Peptide That Suppresses Herpes Simplex Virus 1 Infection: Implications for the Development of Entry-Based Antiviral Therapy
    Jaishankar, Dinesh
    Yakoub, Abraam M.
    Bogdanov, Anita
    Valyi-Nagy, Tibor
    Shukla, Deepak
    JOURNAL OF VIROLOGY, 2015, 89 (03) : 1932 - 1938
  • [30] Development of a Cell-Based Hepatitis C Virus Infection Fluorescent Resonance Energy Transfer Assay for High-Throughput Antiviral Compound Screening
    Yu, Xuemei
    Sainz, Bruno, Jr.
    Uprichard, Susan L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4311 - 4319